FMWA
TMO icon

Forvis Mazars Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Forvis Mazars Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03M Sell
6,034
-1
-0% -$480 0.05% 126
2026
Q1 		$2.97M Sell
6,035
-996
-14% -$541K 0.06% 121
2025
Q4 		$4.07M Sell
7,031
-24
-0.3% -$13.6K 0.08% 107
2025
Q3 		$3.42M Sell
7,055
-328
-4% -$153K 0.07% 114
2025
Q2 		$2.99M Sell
7,383
-241
-3% -$101K 0.06% 122
2025
Q1 		$3.79M Buy
7,624
+452
+6% +$245K 0.09% 106
2024
Q4 		$3.73M Sell
7,172
-237
-3% -$130K 0.09% 109
2024
Q3 		$4.58M Buy
7,409
+271
+4% +$160K 0.11% 97
2024
Q2 		$3.95M Sell
7,138
-141
-2% -$80.8K 0.1% 107
2024
Q1 		$4.23M Buy
7,279
+760
+12% +$426K 0.11% 101
2023
Q4 		$3.46M Buy
6,519
+67
+1% +$32.4K 0.1% 109
2023
Q3 		$3.27M Sell
6,452
-2,188
-25% -$1.17M 0.1% 109
2023
Q2 		$4.51M Buy
8,640
+1,978
+30% +$1.07M 0.13% 101
2023
Q1 		$3.84M Buy
6,662
+543
+9% +$306K 0.13% 101
2022
Q4 		$3.37M Buy
6,119
+121
+2% +$64.1K 0.12% 104
2022
Q3 		$3.04M Buy
5,998
+219
+4% +$123K 0.12% 102
2022
Q2 		$3.14M Buy
5,779
+256
+5% +$141K 0.13% 91
2022
Q1 		$3.26M Buy
5,523
+803
+17% +$461K 0.14% 79
2021
Q4 		$3.15M Buy
4,720
+146
+3% +$91.2K 0.13% 79
2021
Q3 		$2.61M Buy
4,574
+400
+10% +$220K 0.12% 82
2021
Q2 		$2.11M Sell
4,174
-149
-3% -$70.3K 0.1% 92
2021
Q1 		$1.97M Sell
4,323
-2,162
-33% -$1.03M 0.1% 94
2020
Q4 		$3.02M Buy
6,485
+1,039
+19% +$487K 0.15% 75
2020
Q3 		$2.4M Buy
5,446
+195
+4% +$80.6K 0.14% 77
2020
Q2 		$1.9M Buy
5,251
+670
+15% +$225K 0.12% 87
2020
Q1 		$1.3M Buy
4,581
+170
+4% +$53.6K 0.11% 96
2019
Q4 		$1.43M Buy
4,411
+138
+3% +$41.8K 0.1% 103
2019
Q3 		$1.25M Buy
4,273
+53
+1% +$15.2K 0.1% 106
2019
Q2 		$1.24M Buy
4,220
+1,676
+66% +$462K 0.1% 104
2019
Q1 		$696K Buy
2,544
+148
+6% +$36.8K 0.06% 130
2018
Q4 		$536K Buy
2,396
+54
+2% +$12.7K 0.05% 132
2018
Q3 		$572K Buy
2,342
+1,272
+119% +$293K 0.05% 134
2018
Q2 		$222K Sell
1,070
-583
-35% -$124K 0.02% 219
2018
Q1 		$341K Buy
1,653
+568
+52% +$119K 0.03% 185
2017
Q4 		$206K Sell
1,085
-91
-8% -$17.4K 0.02% 232
2017
Q3 		$222K Sell
1,176
-87
-7% -$15.8K 0.02% 210
2017
Q2 		$220K Buy
+1,263
New +$212K 0.02% 209
2016
Q1 		– Sell
-1,444
Closed -$205K – 203
2015
Q4 		$205K Buy
+1,444
New +$193K 0.03% 182

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Forvis Mazars Wealth Advisors's TMO Position: Q2 2026 in Review

Forvis Mazars Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.02% in Q2 2026, selling an estimated $480 and leaving 6,034 shares worth $3.03M. The position accounts for 0.05% of the portfolio, ranked #126.

Forvis Mazars Wealth Advisors first reported a position in TMO in Q4 2015 and has held it in 38 quarters since. The position peaked at $4.58M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Forvis Mazars Wealth Advisors held 6,034 shares of Thermo Fisher Scientific worth $3.03M as of Q2 2026.
  • Forvis Mazars Wealth Advisors sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.05% of Forvis Mazars Wealth Advisors's portfolio in Q2 2026, its #126 holding.
  • Forvis Mazars Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 38 quarters since.
  • Forvis Mazars Wealth Advisors's Thermo Fisher Scientific position peaked at $4.58M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.